Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Walter E. Washington Convention Center

Jun 15, 2025 7:00 AM - Jun 19, 2025 3:00 PM

801 Allen Y. Lew Place, NW, Washington, DC 20001-3614, USA

DIA 2025 Global Annual Meeting

Perspectives on the Adoption of Advanced Manufacturing Technologies

Session Chair(s)

Evdokia  Korakianiti, PhD, MSc

Evdokia Korakianiti, PhD, MSc

Head of Quality and Safety of Medicines

European Medicines Agency, Netherlands

Share regulatory efforts to support advanced manufacturing, including global regulatory developments from EMA and FDA; Listen to Industry cases studies showing implementation journeys and interactions with Regulators globally. Describe avenues available to industry and academia to support development of advanced manufacturing technologies; Discuss remaining challenges and priority areas for Industry and Regulators to work collaboratively to promote the adoption of advanced manufacturing technologies.

Learning Objective : Discuss regulatory efforts to support advanced manufacturing, including global regulatory developments from EMA and FDA; Describe avenues available to industry and academia to support development of advanced manufacturing technologies; Discuss priority areas for regulatory consideration to promote the adoption of advanced manufacturing technologies.

Speaker(s)

Benjamin  Stevens, PhD, MPH

Implementation Journey of a Digital Twin

Benjamin Stevens, PhD, MPH

GlaxoSmithKline, United States

Director CMC Policy and Advocacy

Gert  Thurau, DrSc, PhD

Implementation Journey for AI use in Manufacturing (without hallucinating)

Gert Thurau, DrSc, PhD

F. Hoffmann-La Roche Ltd, Switzerland

Head of CMC Regulatory Policy for Manufacturing Technology Innovation in

Marcel  Hoefnagel, DrSc, PhD, MSc

Enabling Regulatory Frameworks to Foster Innovation - Regulatory Perspective

Marcel Hoefnagel, DrSc, PhD, MSc

Medicines Evaluation Board , Netherlands

Senior Assessor Biopharmaceuticals

Brian  Doyle

mRNA-Based Vaccines: From First Approvals Towards a Platform Technology

Brian Doyle

Moderna, United States

Senior Director, Technical Development

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.